Chronic Lymphatic Leukemia
Links shared publicly online about this topic
SymBio And Eisai To Launch In Singapore For The Treatment Of Low-grade Non-Hodgkin's Lymphoma And Chronic Lymphatic Leukemia
medicalnewstoday.com — “SymBio Pharmaceuticals Limited (Headquarters: Tokyo, President & CEO: Fuminori Yoshida, SymBio) and Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, Eisai) announced that Ei” View full resource at medicalnewstoday.com
Most Recently Shared on September 13, 2010 at 12:37 pm By:
SymBio And Eisai To Launch In Singapore For The Treatment Of Low-grade Non-Hodgkin's Lymphoma And Chronic Lymphatic Leu.. http://dld.bz/v4yd
Chronic Myelogenous Leukemia: eMedicine Hematology
emedicine.medscape.com — “Overview: Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by increased proliferation of the granulocytic cell line without the loss of their capacity to differentiate. Consequently, the peripheral blood cell profile shows an increased number of ...” View full resource at emedicine.medscape.com
Most Recently Shared on March 23, 2010 at 4:52 pm By:
Medscape Oncology Oncology and Health Site
Is dasatinib effective as initial therapy for patients with CML in early chronic phase? Find out at: http://bit.ly/9NzdUd
Chronic Myelogenous Leukemia
webmd.com — “Chronic myelogenous leukemia is a disease in which the bone marrow makes too many white blood cells. Chronic myelogenous leukemia (also called CML or chronic granulocytic leukemia) is a slowly progressing blood and bone marrow disease that usually occurs during or after middle age,and rarely occurs in children. Normally,the body produces bone marrow stem cells (immature cells) that develop ...” View full resource at webmd.com
Most Recently Shared on August 10, 2011 at 12:05 pm By:
Lymphatic filariasis and onchocerciasis : The Lancet
thelancet.com — “Lymphatic filariasis and onchocerciasis. By - Prof Mark J Taylor PhD, Prof Achim Hoerauf MD, Prof Moses Bockarie PhD” View full resource at thelancet.com
Most Recently Shared on August 24, 2010 at 9:21 am By:
What is the second-largest cause of permanent and long-term disability worldwide? Answer, Lymphatic filariasis http://bit.ly/autOkk
Oncology Article | Leukemia Leukemia, Myelomonocytic, Chronic Azacitidine
mdlinx.com — “Activity of azacitidine in chronic myelomonocytic leukemia” View full resource at mdlinx.com
Most Recently Shared on December 24, 2010 at 9:20 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Activity of azacitidine in chronic myelomonocytic leukemia: Cancer http://bit.ly/eaztfF #oncology
Medical News: Formaldehyde Tied to Blood, Lymphatic Cancers - in Hematology/Oncology, Leukemia from MedPage Today
medpagetoday.com — “LITTLE FALLS, N.J. -- Exposure to formaldehyde may be linked to blood and lymphatic cancers, particularly myeloid leukemia, researchers have found.” View full resource at medpagetoday.com
Most Recently Shared on May 14, 2009 at 2:22 pm By:
Formaldehyde Tied to Blood, Lymphatic Cancers http://medpagetoday.com/14207
Medical News: Formaldehyde Tied to Blood, Lymphatic Cancers - in Hematology/Oncology, Leukemia from MedPage Today
medpagetoday.com — “LITTLE FALLS, N.J. -- Exposure to formaldehyde may be linked to blood and lymphatic cancers, particularly myeloid leukemia, researchers have found.” View full resource at medpagetoday.com
Most Recently Shared on May 14, 2009 at 3:19 pm By:
Formaldehyde Tied to Blood, Lymphatic Cancers (CME/CE) http://tinyurl.com/ppfxwf
Leukemia & Lymphoma Society - Chronic Myelogenous Leukemia
leukemia-lymphoma.org — “Fighting leukemia, lymphoma, Hodgkin's disease and myeloma.” View full resource at leukemia-lymphoma.org
Most Recently Shared on November 10, 2009 at 3:02 pm By:
Got a few ?'s about Kareem Abdul-Jabbar's cancer type: CML accounts for only 9% of all leukemias. Here's some info: http://bit.ly/4immfD
Oncology Article | Chronic Disease Leukemia
mdlinx.com — “Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia” View full resource at mdlinx.com
Most Recently Shared on March 21, 2011 at 12:42 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia: Clinical Cancer Research http://bit.ly/dP2zlF #oncology
Chronic Myeloid Leukemia: New Approaches Needed
medicalnewstoday.com — “Chronic myeloid leukemia (CML) was transformed from a fatal disease to a chronic condition by the development of a drug known as imatinib, which targets the protein that drives this disease (BCR-A” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2010 at 1:05 pm By:
Chronic Myeloid Leukemia: New Approaches Needed http://mnt.to/3P3M #lymphoma #leukemia
Leukemia on #MDlinx
mdlinx.com — “Leukemia on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 18, 2010 at 4:19 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: Cancer http://bit.ly/djbdoM #oncology
Leukemia on #MDlinx
mdlinx.com — “Leukemia on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 16, 2010 at 11:20 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: Cancer http://bit.ly/bJf1wO #Nursing
Researchers find new hope for treatment of chronic leukemia
eurekalert.org — “While testing a new drug designed to treat chronic leukemia, researchers at Cleveland Clinic discovered new markers that could identify which patients would receive maximum benefit from the treatment.” View full resource at eurekalert.org
Most Recently Shared on August 17, 2011 at 5:00 pm By:
Researchers find new hope for treatment of chronic #leukemia : http://t.co/JgZSqXt #cancer
NCCN Chronic Myelogenous Leukemia Guidelines Update 2011
secure.quantiamd.com — “Learn about current 2011 and upcoming therapies for Chronic Myelogenous Leukemia from NCCN CML Panel Chair Susan O’Brien, Professor, Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center, University of Texas” View full resource at secure.quantiamd.com
Most Recently Shared on December 14, 2011 at 6:20 pm By:
QuantiaMD Support and Health Social Media
NCCN Chronic Myelogenous Leukemia Guidelines Update 2011 Learn the changes to front line options #CME http://t.co/icTG8lJD
Chronic Myelogenous Leukemia (CML) : Learning Center on Healthline.com
healthline.com — “Chronic myelogenous leukemia is cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells. The cancer grows from cells that produce white blood cells.” View full resource at healthline.com
Most Recently Shared on November 11, 2009 at 7:10 pm By:
Former basketball star Kareem Abdul-Jabbar recently announced that he has been battling chronic myelogenous... http://bit.ly/4jweKx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
medical_tweets
-
Medscape Oncology
Medical news, full text journal articles, clinical reference, expert commentary & community features vital for todays oncologist
-
Michael Whitehead - STNNurse_Mikey
If you treat the disease you win and you lose, but if you treat the person I guarantee you'll win every time. Auxiliary Nurse - Studying Paediatric Nursing at one of the best nursing schools in the country _ Southampton University. Feel free to get in touch, via twitter or facebook!
Advertisement
